Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes

Heart

Volumn 80, Issue 1, 1998, Pages 14-18

  Van Der Wal, A C ^a   Piek, J J ^b   De Boer, O J ^a   Koch, K T ^b   Teeling, P ^a   Van Der Loos, C M ^a   Becker, A E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acute coronary syndromes; Atherosclerosis; Interleukins; T lymphocytes

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ACUTE HEART INFARCTION; ANTIGEN EXPRESSION; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMPENDING HEART INFARCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031858443     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.80.1.14     Document Type: Article

References (32)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
2. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
3. Van der Wal AC, Das PK, Bentz van de Berg DB, et al. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989;61:166-70.
4. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135:169-75.
5. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1991;12:206-11.
6. Stemme S, Faber S, Holm J, et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-7.
7. Van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
8. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995;92:1084-8.
9. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
10. Van der Wal AC, Becker AE, Koch KT, et al. Clinically stable angina is not necessarily associated with histologically stable atherosclerotic plaques. Heart 1996;76:112-17.
11. Waldmann TA. The structure, function and expression of interleukin 2 receptors on normal and malignant lymphocytes. Science 1986;232:727-32.
12. Campeau L. Grading of angina pectoris. Circulation 1976;54:522-3.
13. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
14. Van der Loos CM, Das PK, van den Oord JJM, et al. Multiple immunoenzyme techniques. Use of fluoresceinated, biotinylated and unlabeled antibodies. J Immunol Methods 1989;117:45-52.
15. Stemme S, Hansson GK. Immune mechanisms in atherosclerosis. Coron Artery Dis 1994;5:216-22.
16. Poulton TA, Gallagher A, Potts RC, et al. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulaton. Immunology 1988;64:419-25.
17. Libby P. The molecular basis of acute coronary syndromes. Circulation 1996;91:2844-50.
18. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
19. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. Circulation 1992;86:790-7.
20. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary disease. Am J Cardiol 1990;65:168-72.
21. Jude B, Agraou B, Mc Fadden EP, et al. Evidence for time dependent activation of monocytes in the systemic circulation in stable angina but not in acute myocardial infarction or in stable angina. Circulation 1994; 90:1662-8.
22. Neri Serneri GG, Prisco D, Martini F, et al. Acute T cell activation is detectable in unstable angina. Circulation 1997;95:1806-12.
23. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997;336:1014-5.
24. de Boer OJ, Hirsch F, van der Wal AC, et al. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis 1997;133:277-34.
25. Uyemura K, Demer LL, Castle SC, et al. Cross regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996;97:2130-8.
26. De Boer OJ, van der Wal AC, Das PK, et al. Cytokine profiles of T cell clones from human atherosclerotic plaques [abstract]. J Am Coll Cardiol 1996;27(suppl A):356.
27. Berberian PA, Meyers W, Tytell M, et al. Immunohistochemical localization of heat shock protein-70 in normal appearing and atherosclerotic specimens of human arteries. Am J Pathol 1990;136:71-80.
28. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein-65. Arterioscler Thromb 1992;12: 789-99.
29. Epstein SE, Speir E, Zhou YF, et al. The role of infection in restenosis and atherosclerosis: focus on cytomegaly virus. Lancet 1996;348(suppl I):S13-17.
30. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
31. Frostegard J, Wu R, Giscombe R, et al. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12:461-7.
32. + T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 1996;149;359-66